merus.nl
MERUS - battling cancerbattling cancer
http://www.merus.nl/
battling cancer
http://www.merus.nl/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
PAGES IN
THIS WEBSITE
9
SSL
EXTERNAL LINKS
11
SITE IP
136.144.128.29
LOAD TIME
0 sec
SCORE
6.2
MERUS - battling cancer | merus.nl Reviews
https://merus.nl
battling cancer
Investor Overview - MERUS
Merus discovers and develops differentiated therapeutics aimed at substantially prolonging the lives of cancer patients. It is our strategy to use the power of bispecific antibody engineering and advanced screening technologies to develop biopharmaceuticals that engage the power of the immune system to kill tumor cells. Data provided by Nasdaq. Minimum 15 minutes delayed. There are currently no events scheduled. There are currently no items available.
merus.nl
News - MERUS
http://www.merus.nl/about/about-merus/news
2015 Merus Padualaan 8 3584 CH Utrecht The Netherlands T 31 (0)30 253 88 00 enquiries@merus.nl.
Merus investors
http://www.merus.nl/investors
Merus to Present at the 2016 Wedbush PacGrow Healthcare Conference. Posted on 10 August, 2016 at 11:00 am. Merus Announces Second Quarter 2016 Financial Results and Reviews Recent Clinical Progress and Corporate Developments. Posted on 8 August, 2016 at 11:01 am. Merus Announces First Quarter 2016 Financial Results and Highlights Recent Clinical Progress and Corporate Developments. Posted on 12 July, 2016 at 12:19 pm. Posted on 1 June, 2016 at 1:21 pm. Posted on 31 May, 2016 at 3:29 pm.
Pipeline - MERUS
http://www.merus.nl/pipeline
Our pipeline comprises Biclonics. For solid and hematological tumors. MCLA-128 is an ADCC-enhanced Biclonics. MCLA-117 is a Biclonics. That binds to CD3, a cell-surface molecule present on all T cells, and CLEC12A, a cell surface molecule present on Acute Myleoid Leukemia (AML) cells and stem cells. MCLA-117 is designed to recruit and activate T-cells to kill CLEC12A-expressing AML tumor cells and stem cells, which may prevent recurrence of tumors. MCLA-158 is an ADCC-enhanced Biclonics. We intend to lev...
Merus Prevails in Inequitable Conduct Case Against Regeneron - MERUS
http://www.merus.nl/merus-prevails-in-inequitable-conduct-case-against-regeneron
Merus Prevails in Inequitable Conduct Case Against Regeneron. 10 August, 2015. Court ruling further strengthens Merus’ freedom to operate in using transgenic mice for therapeutic human antibodies. Utrecht, The Netherlands, August 10, 2015. About Merus B.V. Media Inquiries for Merus:. Dr Ludger Wess or Ines-Regina Buth. Tel 49 (0)40 88 16 59 64 / 49 (0)30 2363 2768. Company Inquiries for Merus:. S Margetson – s.margetson@merus.nl. 3584CH Utrecht, The Netherlands. Posted on 10 August, 2016 at 11:00 am.
Merus and Selexis receive a € 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer - MERUS
http://www.merus.nl/merus-and-selexis-receive-a-e-2-1-million-grant-for-single-cell-line-manufacturing-of-a-bispecific-antibody-combination-to-treat-colorectal-cancer
Merus and Selexis receive a 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer. 20 May, 2015. Utrecht, The Netherlands, May 20, 2015. In the program, Merus and Selexis will combine their unique and proprietary Oligoclonics. Candidate was discovered as part of a previous EUREKA program and will be produced from a single manufacturing cell line developed by Selexis. Combining drugs is at the heart of therapeutic approaches to cancer, said Ma...
TOTAL PAGES IN THIS WEBSITE
9
suppresSTEM Participants - suppresSTEM
http://suppresstem.eu/suppresstem-participants
June 20, 2014. SuppresSTEM consortium attending AACR-EORTC-NCI International Conference on Molecular Targets and Cancer Therapeutics (Boston, 5-9 Nov 2015) with 2 posters C21. Successful release of suppresSTEM website, August 2014. Kick-off suppresSTEM date, 1st June 2013.
Portfolio - Aglaia Biomedical Ventures
http://www.aglaia-biomedical.com/portfolio
Eric van der Putten. News & Events. InteRNA Technologies B.V. Development of cancer therapies based on the unique functions miRNAs. Drugs against ‘undruggable’ targets: Small Molecule Helix Mimetics. ISA Pharmaceuticals B.V. Fully synthetic therapeutic vaccines against cancer and persistent viral infections. Bispecific antibodies which are targeting solid tumors and blood tumors. ORCA Therapeutics B.V. Development of angiogenesis inhibitors for the treatment of solid cancers. Juni 3, 2016. Juni 1, 2016.
Merus reaches pivotal milestone in bispecific antibody collaboration with ONO PHARMACEUTICAL CO., LTD. | the akampioneer
http://akampioneer.com/company-news/company-news-merus-reaches-pivotal-milestone-in-bispecific-antibody-collaboration-with-ono-pharmaceutical-co-ltd.html
Company News: Merus reaches pivotal milestone in bispecific antibody collaboration with ONO PHARMACEUTICAL CO., LTD. Wednesday, April 8, 2015. Successful product lead identification underscores the strength of Merus’ platform in delivering human, full-length IgG bispecific antibodies -. Posted in Company News. Full-length IgG bispecific antibodies. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed. Company News: New CELL Study presents groundbrea...
Merus publications - suppresSTEM
http://suppresstem.eu/key-suppresstem-publications/merus
July 24, 2014. Key suppresSTEM publications Merus. De Kruif, J., A. Kramer, et al. (2009). “Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.” J Mol Biol 387: 548-558. PMID: 19361421. De Kruif, J., A. Kramer, et al. (2010). Generation of stable cell clones expressing mixtures of human antibodies. Biotechnol Bioeng 106: 741-750. PMID: 20564612. For ongoing work from Merus please visit their website.
Key suppresSTEM publications
http://suppresstem.eu/key-suppresstem-publications
July 2, 2014. SuppresSTEM consortium attending AACR-EORTC-NCI International Conference on Molecular Targets and Cancer Therapeutics (Boston, 5-9 Nov 2015) with 2 posters C21. Successful release of suppresSTEM website, August 2014. Kick-off suppresSTEM date, 1st June 2013.
My clients - Scicomvisuals
http://www.scicomvisuals.com/about-me/my-clients
SCICOMVISUALS focuses on clients in pharma, biotechnology and education. Assigned projects range from educating infographics and informative scientific posters, to websites, animated movies and corporate identity. Working closely with true professionals, a diverse set of communication projects can be handled in parallel. This way, you can be sure your complex messages are translated into compelling and clear visuals of the highest standard that are understood by your audience. Virtual lab tour live!
TOTAL LINKS TO THIS WEBSITE
11
Merus – Tratamiento de agua, Verde y sustentable desde 1996
Merus Tratamiento de agua, Verde. Y sustentable desde 1996. El Anillo MERUS tratamiento de agua para combatir incrustaciones, corrosión, obstrucciones, ensuciamiento y biopelícula en circuitos de enfriamiento e intercambiadores de calor. MERUS se dedica a la solución de los problemas que surgen de la utilización del agua. Esto incluye, no solamente el tratamiento del agua potable, sino también el tratamiento de todo tipo de agua utilizado en el sector industrial hoy en día. Reducción de la Corrosión.
Synergia Foxy - tehokas julkaisujärjestelmä pienille ja suurille yrityksille
Synergia Foxy on Mainostoimisto Synergian kehittämä tehokas sisällönhallintajärjestelmä. Kuuntelimme asiakkaidemme tarpeita ja kehitimme niitä vastaavan järjestelmän, jonka käyttö on uskomattoman helppoa. Muutamalla klikkauksella olet päivittänyt sivujesi sisällön kätevästi kotikoneeltasi. Emme ole laittaneet tuotteeseemme keinotekoisia rajoituksia, vaan saat 33,5 /kk kuukausihintaan. Basic-paketti sisältää hyvän aloitus- paketin sivujen rakentamiseen. Ulkoasusuunnitelma asiakkaalta. 12102009 Popupien mä...
Merus Software Ltd.
Merus and Mercatum are trademarks of Merus Software Ltd. Your success is our aim. Are you looking for a superb internet trading platform for your business? At Merus we are specialists in tailor-made, integrated on-line catalogue solutions. Our complete, cost-effective systems are carefully designed to provide unmatched performance for you, your customers and business partners. With Merus, even complex, high volume requirements are transformed into smooth-running, scalable operations tailored to your needs.
Merus Software Ltd.
Merus and Mercatum are trademarks of Merus Software Ltd. Your success is our aim. Are you looking for a superb internet trading platform for your business? At Merus we are specialists in tailor-made, integrated on-line catalogue solutions. Our complete, cost-effective systems are carefully designed to provide unmatched performance for you, your customers and business partners. With Merus, even complex, high volume requirements are transformed into smooth-running, scalable operations tailored to your needs.
MERUS - battling cancer
For Superior Clinical Efficacy. Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics. Are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways. APPLICATION OF IMODS IN IMMUNO-ONCOLOGY. For our iMOD programs, Biclonics. Our pipeline comprises Biclonics. Merus and Selexis rece...
merus.org
Merus.pl może należeć do Ciebie
100 nazw dla firm. Może należeć do Ciebie. Stwórz silną markę, by sprzedawać więcej i drożej. Jesteś zainteresowany Merus.pl. Nazwa firmy z końcówką .pl jest coraz częściej umieszczana w szyldzie firmy. Na nazwę dla firmy, marki, strony, sklepu internetowego:. Co Ci da dobry adres www? Adres strony jest tysiące razy. Wpisywany na klawiaturze, wymawiany i dyktowany. Reklamie, wizytówce, jest widoczny w poczcie e-mail. Może wspomóc albo utrudnić. Sprzedaż Twoich produktów i usług. Sprzedawaj więcej i drożej.
MERUS d.o.o., Beograd - Digitalni printeri i rezači, laser, tisak CD/DVD, statičkog elektriciteta - MERUS d.o.o., Beograd
Merus-hr d.o.o. Merus-hr d.o.o. Digitalni tiskalniki in rezalniki, laser, tisk CD/DVD, statika - Merus-hr d.o.o. Merus-hr d.o.o. Prodaja digitalne strojne opreme za tiskanje in razrez, Merus-hr d.o.o. Opreme za nevtralizacijo statične elektrike, Merus-hr d.o.o. Sistemov za snemanje in tisk na CD/DVD medije za namene v različnih industrijskih panogah, Merus-hr d.o.o. Prodaja potrošnega materiala za ponujene prodajne programe. Merus d.o.o., Merus-hr d.o.o. Merus d.o.o., Merus-hr d.o.o. Mysql error . .
Merusa news
10 YEARS - - - MERUSA RECORDS - - - 10 YEARS. Special offer: All Latin CD's 4.99! To celebrate our 10th anniversary we have a very special offer! All our Latin-American CD productions on the Merusa Records label are now on sale for only 4.99 each! This includes the records by the Toro Ensamble, San Millán, Mate, Caracas Kontambor, Zumbao, Alberto Naranjo, FP Barrio Nuevo, our compilations of Venezuelan jazz and ska, and many more. Check it out! New CD by La Manouche. New CD by FP Barrio Nuevo. FP Barrio ...
SOCIAL ENGAGEMENT